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Speech is an attribute of the human species. Central speech disorders following stroke are unique models
for the investigation of the organization of speech. Achievements in neurobiology suggest that there are
possible neuroendocrine mechanisms involved in the organization of speech. It is known that the
neuropeptide vasotocin, analogous of vasopressin in mammals, modulates various components of
vocalization in animals. Furthermore, the positive influence of vasopressin on memory, which plays an
important role in the formation of speech, has been described. In this study, speech organization processes
and their recovery with the administration of vasopressin (1-desamino-8-D-arginin-vasopressin) to 26
patients with chronic aphasias after stroke were investigated. Results showed that sub-endocrine doses
of the neuropeptide with intranasal administration had positive influence primarily on simple forms of
speech and secondarily on composite forms. There were no statistically significant differences between
the sensory and integrative components of the organization of speech processes with vasopressin. In all
cases, the positive effect of the neuropeptide was demonstrated. As a result of the effects, speech regulated
by both brain hemispheres improved. It is suggested that the neuropeptide optimizes the activity both in
the left and right hemispheres, with primary influence on the right hemisphere. The persistence of the
acquired effects is explained by an induction of compensatory processes resulting in the reorganization
of the intra-central connections by vasopressin. 
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El habla es un atributo de la especie humana. Los trastornos centrales del habla después de una trombosis
cerebral son modelos únicos para la investigación de la organización del habla. Los logros en la
neurobiología sugieren que posiblemente haya mecanismos neuroendocrinos implicados en la organización
del habla. Se sabe que el neuropéptido vasotocina, análogo de la vasopresina en los mamíferos, modula
varios componentes de la vocalización en los animales. Además, se ha descrito la influencia positiva de
la vasopresina en la memoria, que juega un papel importante en la formación del habla. En este estudio,
se investigaron los procesos de la organización del habla y su recuperación con la administración de la
vasopresina (1-desamino-8-D-arginin-vasopressin) a 26 pacientes con afasias crónicas después de una
trombosis cerebral. Los resultados mostraron que las dosis sub-endocrinas del neuropéptido con
administración intranasal tuvo influencia positiva primariamente en las formas simples del habla y, de
manera secundaria, en las formas compuestas. No hubo diferencias estadísticamente significativas entre
los componentes sensoriales e integrativos de la organización de los procesos del habla con vasopresina.
En todos los casos, se demostró el efecto positivo del neuropéptido. Como resultado de los efectos,
mejoró el habla regulado por ambos hemisferios. Se sugiere que el neuropéptido optimiza la actividad
tanto en el hemisferio izquierdo como en el derecho, con influencia primaria sobre el hemisferio derecho.
La persistencia de los efectos adquiridos se explica por la inducción de procesos compensatorios como
resultado de la reorganización de las conexiones intra-centrales por la vasopresina.
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Speech is a higher cortical function that is a complex
and finely differentiated act with multilevel organization.
Until recently, the understanding of the biochemical and
neurophysiological basis for speech has remained limited.
Despite much research, the problem of language competence
of the brain hemispheres is still relevant. Specific language
functions of the hemispheres have been studied at various
levels: in volunteers, in patients following commissurotomy,
in patients with organic brain damage, and in psychiatric
diseases in conditions of transient hemisphere inactivation.
(Balonov & Deglin, 1976; Buckner, Corbetta, Schatz,
Raichle, & Petersen, 1996; Chertkow, Bub, Deaudon, &
Whitehead, 1997; Gazzaniga, 1995; Loddenkemper et al.,
2004; Luria, 1970; Luria & Hutton, 1977; Murphy et al.,
1997; Nikolaenko & Egorov, 1998; Njiokikjien, Sonneville,
& Vaal, 1994; Semmens, 1968; Sperry, Gazzaniga, & Bogen,
1969; Weiller et al., 1995; Wise, 2003). 
The role of the dominant hemisphere (usually the left
hemisphere in right-handed subjects) in the organization of
speech and language has been relatively fully researched. It
has been demonstrated that the principal speech zones, which
function as a whole due to inter-cortical and cortico-subcortical
connections, are within the left hemisphere (Buckner et al.,
1996; Radanovic & Scaff, 2003). Usually the left hemisphere
recognizes more rapidly infrequent (rare), morphologically
complex, abstract words, adjectives, and verbs (Efron, 1990;
Eviatar, Zaidel, & Menn, 1990; Goodal, 1984; Sperry et al.,
1969; Zaidel, 1978, 1989). It is also is involved in the
formation of speech motor programs, and the last structure
of declared speech (Luria, 1970; Luria & Hutton, 1977).
Included in the functions of this hemisphere is the ability to
produce speech. It is also responsible for highly specialized
linguistic mechanisms of phonetic decoding and analysis
(Sharp, Scott, & Wise, 2004; Sperry et al., 1969; Zaidel,
1978). Also included in the functions of the left hemisphere
are phonetic hearing or audio-verbal gnosis, writing, and
reading (Dronkers, Wilkins, van Valin, Redfern, & Jaeger,
2004; Hagoort, 1993; Larsen, Skinhoj, & Lassen, 1979;
Saygin, Wilson, Dronkers, & Bates, 2004). In left-sided injury
to the superior temporal and angular gyrus, comprehension
of speech is impaired (Dronkers et al.; Josse & Tzourio-
Mazoyer, 2004). The structures of the left hemisphere form
the morphological substrate for logical thought.
The right hemisphere recognizes simple single-syllable
common (frequent) concrete nouns and sentences consisting
of simple words (Goodal, 1984; Nikolaenko & Egorov, 1998).
It is considered to participate partially in the comprehension
of spoken and written speech, and it accepts, analyzes, and
stores holistic components of speech or indivisible code units
(Sperry et al., 1969; Zaidel, 1978). It has been determined
that the right hemisphere perceives words according to their
acoustic but not phonetic features. The activity of this
hemisphere has been associated with the perception and
reproduction of the acoustic contour of words, silent reading
of simple words, and the analysis of non-verbal prosodic
elements of speech (Ghacibeh & Heilman, 2003, Heilman,
Leon, & Rosenbek, 2004; Sperry et al., 1969). It dominates
in the establishment of common links between various aspects
of information leading to the formation of the prerequisites
for simplified context identification and the creation of a
holistic impression. Included in the functions of the right
hemisphere is the imprinting of words in orthographic form—
type, letter, color, etc.—(Sperry et al.; Zaidel). It is essential
in associative–empirical thought, although it is considered
to lack the ability to form the movements required for the
production of speech. Thus, research over the past decades
provides evidence for the fact that the intact brain acts as a
whole by means of the interaction of the hemispheres, and
yet, each hemisphere is functionally specific for the
performance of various aspects of speech (Zaidel; Nikolaenko
& Egorov).
The most severe and widespread speech disturbance is
post-stroke aphasia. Aphasia is central damage to previously
fully formed speech in subjects with intact articulation and
hearing, with partial or complete loss of the ability to use
words for the expression of thought and the comprehension
of directed speech (Nikiforov, 1997; Saygin et al., 2004).
Aphasia is present in up to 38-54 % of patients following
stroke (Pedersen, Jorgensen, Nakayama, Raaschou, & Olsen,
1995). Such speech disturbances result from focal injury to
cortical and subcortical structures of the hemisphere specific
for speech (usually in the left hemisphere in right-handed
subjects). These disturbances are of systemic nature, with
disruption of expressive and impressive speech (Clark, 1994;
Druks & Marshall, 1995; Chertkow et al., 1997).
On the basis of neuropsychological research by Luria
(Luria, 1970; Luria & Hutton, 1977), various forms of
aphasia are explained by defects in various components
(factors) of the function of speech (efferent, afferent, etc.).
There are several forms of aphasia depending on the
localization of brain damage. Amnestic or acoustico-amnestic
aphasia occurs in left-sided (in right-handed subjects)
occlusion of distal sections of the median cerebral artery.
In these cases, ischemia occurs within the medial gyrus of
the temporal lobe—Brodman areas 37 and 40—(Karbe et
al., 1995; Luria, 1970; Luria & Hutton 1977). In acoustico-
amnestic aphasia, disturbance in retention and reproduction
of verbal material is associated with increased retro- and
proactive verbal trace inhibition. Here, spontaneous speech
is characterized by searches for required words and frequent
verbal paraphasias. Central in such speech disturbance is
the disturbance of audio-verbal memory, which manifests
in defects of object naming and related actions, and
impairment of aural retention of auditory and verbal series.
Patients are able to reproduce no more that two or three
elements of the series, whereas normally, the volume of
short-term auditory verbal memory consists on average of
7±2 units. Secondly, as a result of a decrease in verbal
information processing, there is impairment of directed
speech comprehension.
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Acoustico-agnostic aphasia occurs in stenosis or
occlusion of distal portions of the left (in right-handed
subjects) median cerebral artery, with the formation of the
brain lesion within the superior temporal gyrus in Wernicke’s
area—Brodman areas 21 and 22—(Abo et al., 2004; Luria,
1970). Acoustico-agnostic aphasia or fluent aphasia is
essentially equivalent to Wernicke’s sensory aphasia. The
primary defect in such forms of central speech impairment
is the disturbance of phonetic hearing or audio-verbal gnosis
(Sharp, Scott, & Wise, 2004). In acoustico-agnostic aphasia
differentiation of sounds and words, differing in some trait
(sonority, hardness), is impaired. In this case, the primary
defects of impressive speech manifest in the impairment of
comprehension of oral and written speech (Hagoort, 1993).
Expressive speech is impaired secondarily as a result of the
deficiency of aural control of the patient’s own speech
(Druks & Marshall, 1995). In severe disorders, the patient’s
speech becomes incomprehensible as a result of a multitude
of literal and verbal paraphasias—substitutions and omissions
of sounds and words—(Vasserman, Dorofeeva, & Meerson,
1997). Also present is speech disinhibition (logorrhea). It
has been shown that in such forms of aphasia, there is
impairment of short-term acoustic and long-term semantic
memory (Beeson, Bayles, Rubens, & Kaszniak, 1993;
Graham, Hodges, & Patterson, 1994; Ronnberg et al., 1996).
Different forms of aphasia following focal brain injury
present a valuable model for the study of speech organization
in its entirety, and in its components related to perception,
comprehension, and production. Using the analysis of
spontaneous and induced recovery of speech, it is possible
to identify the specific input of the brain hemispheres in
communication and to study the neurochemical and
neurohumoral components of speech regulation. 
A stroke is an acute disruption of brain blood circulation
manifesting with deficit brain function lasting no less than
24 hours (Vilenski, 1995; Whisnant, Basford, & Bernstein,
1990). Ischemic strokes are more frequent than brain
hemorrhages. During the process of infarct formation, there
is necrosis in the central part of the ischemic zone and
formation of an area of relative ischemia (ischemic
penumbra), which is a region of unstable brain tissue
metabolism. The velocity of brain blood-flow within the
ischemic penumbra is greater than the level at which brain
cell death occurs, and therefore, neurons are able to maintain
a state of unstable metabolism (Kassel & Torner, 1984). On
the contrary, within the infarct, blood flow is insufficient
for the maintenance of normal electrophysiological neuronal
activity and leads to cell death—apoptosis—(Kerr, Wyllie,
& Currie, 1972; Nitatori, 1995). Thus, the rate and extent
of speech and other function recovery depends on the level
of collateral circulation and the activation of functionally
inactive reserve connections of the regions surrounding the
necrotic area (Kassel & Torner).
Despite extensive experience in the development of
speech rehabilitation in aphasias (Fernandez et al., 2004;
Perani et al., 2003; Weiller et al., 1995; Xu et al., 2004;
Zahn et al., 2004), the neurochemical mechanisms of speech
compensation in speech impairment and the role of the
hemispheres in this process are still poorly understood. 
Over the past years, data has been compiled proving the
existence of a neuro-endocrine component of speech
regulation. A high density of vasopressin receptors has been
revealed in a number of mammal brain areas involved in
vocalization (Boyd, 1997; Brudzynski, Eckersdorf, &
Golebiewski, 1995; Voorhuis, Kloet, & Wied, 1988). On the
other hand, in experiments with injury to central motor
analyzer regions, the neuropeptide vasopressin induces the
reorganization of intra-central connections leading to the
recovery of motor function (Vartanian & Klementiev, 1991).
It is known that vasopressin possesses anti-amnestic
properties (Vawter, Wied, & van Ree, 1997; Wied, Diamant,
& Fodor, 1993). In turn, aphasia is accompanied by
impairment of verbal memory (Beeson, Bayles, Rubens, &
Kaszniak, 1993; Radanovic & Scaff, 2003; Martin & He,
2004; Ullman, 2004; Ween, Verfaellie, & Alexander, 1996).
See in Table 1 some examples of the influence of vasopressin
on speech in various forms of aphasia.
The aim of this study was to evaluate the state of speech
functions in patients with acoustico-agnostic and acoustico-
amnestic aphasia of vascular origin under the influence of
the neuropeptide arginin-vasopressin. 
Method
Participants
The study included 26 patients with aphasia following
stroke: 17 male subjects (65%) and 9 female subjects (35%)
with mean age 61.4±3 years and mean duration of post-
stroke period of 1.4±0.1 years. Thus, the patients selected
for the study were in the residual stage of stroke. All
participants were right-handed. In a majority of the patients,
the etiology of stroke factors was the combination of
atherosclerosis and arterial hypertension (76%); in the
remaining patients, the etiology of stroke was cerebral vessel
atherosclerosis, rheumatic heart disease with
thromboembolism, cerebral vessel aneurism, and thrombosis
of unknown origin (24%). 
Assessment
In all cases, aphasia was the consequence of ischemic
stroke in the territory of the left middle cerebral artery. In
each patient, diagnosis was confirmed by the results of
computerized and/or magnetic resonance tomography. In
cases of stroke with a predominance of damage to the
superior temporal gyrus, there was acoustico-agnostic
aphasia; with damage predominantly to the medial temporal
gyrus, there was acoustico-amnestic aphasia. 
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Diagnosis was made according to the classification of
Luria (Luria, 1970; Luria & Hutton, 1977). Acoustico-
agnostic aphasia was diagnosed in 16 patients, and acoustico-
amnestic aphasia in 10. Neuropsychological testing included
the assessment of expressive and impressive speech of the
patients (Vasserman et al., 1997). The patients own speech
was characterized by spontaneous, dialogue, and automatic
speech (serial counting from 1 to 10, naming of week days
and months), and narrative speech (formation of sentences
and stories according to illustrations, retelling of simple
texts). Repetition speech was assessed by the repetition of
simple words, word series, vowels and consonants, complex
and simple foreign (English) words, series of sounds and
syllables, complex sentences, oppositional series of syllables
and words. Nominative function was defined as the patient’s
ability to name objects and actions (according to illustrations
of objects and actions). 
Speech comprehension was assessed during conversations
with the patients. The comprehension of everyday speech,
simple instructions, separate words, and complex
grammatical constructions was assessed. The presence of
word sense alienation of objects and face parts was
evaluated. Acoustic-verbal memory was assessed by the
retention of speech series (series of vowels and consonants,
syllables, words, and simple sentences). Phonetic analysis
included word analysis with one or two phonemes, letter
choice at the beginning or end of words, the definition of
the phonetic components of words presented by the
investigator and visually presented on images. The reading
of syllables, simple words, and automatic ideograms, letters,
written instructions, complex words, sentences, and text out
loud, matching picture to text, and silent reading and
comprehension was assessed. Writing was assessed by
copying of simple phrases, writing by dictation, automatic
engrams (speech stereotypes), letters, syllables, words,
phrases, independent written object-naming, formation of
words from letters. 
All indices were rated using a 4-point system in which
0 corresponded to correct execution of task (no impairment);
1 point to mild impairment; 2 points to moderate impairment;
3 points to severe impairment.
Materials and Procedure 
1-desamino-8-D-arginine-vasopressin (desmopressin), a
selective vasopressin V2-receptor agonist, was administered
intranasally fractionally for the duration of 1.5-2 months
with a single dose of 0.1µg and total dosage of 4µg.
Assessment of the effect of the medication was carried out
using a scale in which improvement in no less than three
aspects of speech indicated a good effect; in two
components, a satisfactory effect; and in one component, a
minimal effect. 
The control group consisted of the same 26 patients who,
prior to the intranasal administration of vasopressin were
administered an intranasal sterile physiological saline solution
(placebo) for 2 weeks in the same regimen as the consecutive
vasopressin administration.  The study was carried out under
double blind controlled conditions. Follow-up investigation
and repeated administration of arginine-vasopressin were
carried out in these same 26 patients with aphasia 1-2 years
after completion of the first course.
For the interpretation of the effect of vasopressin, speech
was examined as a functional system, the afferent, central
and efferent components of which correspond to the
processes of perception, comprehension, and production of
speech, (i.e., the sensory, integrative, and motor components).
In order to assess these components, specific
neuropsychological tests were used to rate the separate
components of speech. 
The sensory component of speech was characterized by
indices such as: speech comprehension, writing by dictation,
phonetic analysis, silent reading, and its comprehension.
The integrative component, reflecting the state of acoustico-
verbal memory, was evaluated by the retention of auditory
verbal series (repetition of a series of vowels and consonants,
words and sentences), object naming, and matching picture
with text. Changes in the separate components of speech
were assessed by comparing the total arithmetic mean values
prior to the administration of the neuropeptide arginine-
vasopressin, after placebo and subsequent to the course of
treatment after 1_-2 months. During the period of
investigation, the patients continued to take medication
previously prescribed, such as antiaggregant and/or
hypotensive drugs. 
To identify speech components that changed significantly
under the influence of vasopressin, we used paired-samples
Student’s t-test. 
Results
Speech improvement was noted in 23 patients (88% of
cases) following the administration of vasopressin. Selectivity
of the effects of the neuropeptide was revealed. One hundred
percent of the cases with acoustico-amnestic aphasia and
90% with acoustico-agnostic aphasia showed improvement
following treatment (see Table 1). 
In the cases with acoustico-amnestic aphasia, recovery
was noted in the fields of both the expressive and impressive
components of speech (see Table 2). Within this group, there
was improvement of independent speech (p < .05), including
spontaneous speech (p < .05). Patients showed an increase
in active vocabulary: They were able to remember simple
words with greater ease. In speech production, there were
less frequent pauses, verbal, and literal paraphasias ( p <
.05). Text retelling in a majority of patients became more
detailed as a result of an increase in the amount of words
per sentence (p < .05). There was a significant improvement
in naming (p < .05), including the naming of separate items
(p < .05). As a result of optimization of acoustico-verbal
memory in patients with acoustico-amnestic aphasia, there
was a secondary improvement in phonetic analysis (p < .05).
Following treatment with arginine-vasopressin, patients more
often correctly analyzed the phonetic composition of recalled
simple words (p < .05). It is a well known fact that the
primary component of speech impairment in cases of
acoustico-amnestic aphasia is a defect in either audio-verbal
memory (Luria, 1970) or in the integrative component of
speech. Vasopressin induced the recovery of the integrative
component of speech in these patients (p < .01), as shown
in Figure 1. There was no placebo-effect in this group. 
Thus, the present study demonstrated the efficacy of
vasopressin in the correction of systemic speech impairment
in acoustico-amnestic aphasia. A more defined positive effect
in these disturbances was noted in the expressive component
of speech. The therapeutic effect of vasopressin in patients
with acoustico-amnestic aphasia was characterized by
recovery of the integrative component of speech. First,
arginine-vasopressin restored relatively simple speech forms
(automatic speech, object naming), and then complex forms. 
Case 1 illustrates the influence of vasopressin on speech
in cases of acoustico-amnestic aphasia. Patient no. 4 (see
Table 3), 56 years, with higher education (by profession an
economist), right-handed with arterial hypertension and
cerebral atherosclerosis, suffered an ischemic stroke in the
territory of the left middle cerebral artery. Following the
stroke, the patient developed acoustico-amnestic aphasia and
mild right-sided hemiparesis. He was admitted into a
municipal hospital. On admission, he complained of difficulty
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Figure 1. The effect of DDAVP (1-desamino-8-D-arginine-
vasopressin).on the sensory and integrative components of speech
in patients with acoustico-agnostic and acoustico-amnestic aphasia.
Y-axis = severity of speech impairment in points. 
* p < .01 significance of variance.
Table 1
The Influence of DDAVP on Speech in Various Forms of Aphasia
Effect of the administration of DDAVP in aphasia
Good Satisfactory        Insignificant            Absent    Good positive 
effect
n (%) n (%) n (%) n (%) n (%)
Acoustico-amnestic 16 7 (44) 5 (31) 4 (25) 0 (0) 14 (100)
Acoustico-agnostic 10 6 (60) 0 (0) 3 (30) 1 (10) 9 (90)
Total number (%) 26 13 (50) 5 (19) 7 (27) 1 (4) 23 (88)
Note. DDAVP = 1-desamino-8-D-arginine-vasopressin.
Table 2
The Effect of Vasopressin on Speech in Acoustico-Amnestic Aphasia (M ± m, rate)
N Indices of speech activities                             Prior to treatment Following treatment
1.0 Independent speech 1.0 ± 0.1 0.7 ± 0.1*
1.1 Spontaneous speech 1.2 ± 0.2 0.8 ± 0.1*
1.2 Dialogue 0.8 ± 0.2 0.4 ± 0.2*
1.3 Automatic: listing of months 0.7 ± 0.2 0.2 ± 0.2*
1.4 Narrative speech (text re-telling) 1.9 ± 0.2 1.4 ± 0.2*
2.0 Paraphasias 0.9 ± 0.1 0.6 ± 0.1*
3.0 Naming 1.6 ± 0.1 1.3 ± 0.1*
3.1 Item naming 2.0 ± 0.2 1.4 ± 0.2*
4.0 Phonetic analysis 1.0 ± 0.1 0.5 ± 0.1*
4.1 Analysis of recollected words 1.3 ± 0.2 0.4 ± 0.2*
Note. N = 1.0, 2.0, 3.0, 4.0 = several parts of speech function.
1.1, 1.2, 1.3, 1.4; 3.1; 4.1 = sample components of relative speech function. 
* = significant changes in indices after treatment course with DDAVP (p < .05 in all variances).
Forms of aphasia      Number of subjects
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speaking and weakness in the right extremities. During the
acute period post-stroke period, he received conventional
medication and speech therapy. He was then discharged for
out-patient treatment. Five months after the stroke, the patient’s
speech consisted only of simple words, that is, speech
remained significantly impaired, leading to difficulty in
communication. One and a half years after the stroke, the
patient was admitted to the neurological rehabilitation
department of the V.M. Bekhterev Saint Petersburg
Psychoneurological Research Institute. Prior to the course of
treatment with vasopressin, the patient was examined using
neurological and neuropsychological methods. Moderate
acoustico-amnestic aphasia and mild right-sided hemiparesis
were diagnosed. The patient’s expressive speech was
unintelligible due to a large amount of verbal substitutions
(see Table 3). Repetition was impaired non-uniformly:
impairment was present only in relation to the repetition of
sound and speech series. Pronunciation was normal. Distinct
difficulties occurred in attempts to name objects and related
actions. Comprehension of daily activity speech was intact
with impairment only in relation to complex grammatical
constructions. Written speech had more significant impairment:
The patient was only able to write separate words and copy
simple sentences. Phonetic analysis and reading were
significantly damaged. The patient’s speech was impregnated
with paraphasias. There was no placebo effect. The patient
was administered a course of treatment with arginine-
vasopressin: intranasal single administration of 0.1µg of the
neuropeptide daily for 2 months with a total dosage of 4µg.
After treatment, there was an improvement in expressive
speech, including spontaneous, dialogue, and automatic
speech (see Table 3). Changes in repetition were less
pronounced, with an improvement in retention and repetition
of a series of vowels and “pseudo-words.” There was
significant improvement in object naming. When naming
objects and in related actions, paraphasias occurred less
frequently than before. The patient experienced less difficulty
in the comprehension of grammatical constructions. There
was less alienation of word sense for face parts. On the
whole, there was no change in writing, although there was
a decrease in the amount of paragraphias. There was
significant regression of impairments of phonetic analysis
and reading. Thus, there was a positive effect of arginine-
vasopressin on speech in a patient with moderate acoustico-
amnestic aphasia in the remote period following stroke. In
this patient, improvement in speech following one course of
treatment was persistent, as the improvement continued to
be present at follow-up (1/2 year after completion of the first
course). There were no adverse effects in the above-described
administration of the neuropeptide arginine-vasopressin. 
In cases of acoustico-agnostic aphasia, the administration
of vasopressin also led to a regression of systemic speech
impairment: primary impairment of the impressive component,
typical for these forms of aphasia, and secondary impairment
of expressive speech. In patients with acoustico-agnostic aphasia,
there was significant improvement of writing (p < .01). In
written object naming, paragraphias were less frequent (p <
.05). In the majority of patients, reading improved (p < .05).
Table 3
The Effect of DDAVP on Speech in Patients with Acoustico-Amnestic Aphasia
Subject Time following Severity of speech Separate components of speech Treatment
no. stroke (years) impairment   IS Rep. N Com W PA Read Para results
1 1.1 Severe 2/2 2/2 3/3 2/2 3/3 2/1 3/3 2/2 Insignificant
2 1.0 Moderate 1/1 1/1 2/1 1/1 2/2 2/1 2/2 1/1 Satisfactory
3 1.0 Moderate 2/2 2/2 3/2 1/1 2/2 2/0 2/2 1/1 Satisfactory
4 1.5 Moderate 2/1 1/1 2/1 2/1 2/2 2/1 3/2 1/0 Good
5 1.0 Mild 1/0 0 1/0 1/0 1/0 1/1 1/0 1/0 Good
6 1.4 Mild 1/0 0 1/0 1/0 1/0 1/1 1/1 1/0 Good
7 1.0 Mild 1/0 0 1/0 1/0 1/0 1/0 1/0 1/0 Good
8 1.0 Mild 1/1 1/1 2/1 1/1 1/1 2/2 0 1/0 Satisfactory
9 1.1 Mild 1/1 1/0 1/0 1/1 0 0 0 1/1 Satisfactory
10 1.4 Mild 1/0 0 1/0 1/0 1/0 0 1/0 1/0 Good
11 1.1 Mild 1/0 0 1/0 1/0 1/0 1/0 1/0 1/0 Good
12 1.5 Mild 1/0 0 1/0 1/0 1/0 0 1/0 1/0 Good.
13 1.1 Mild 1/1 1/0 1/0 1/1 0 0 0 1/1 Satisfactory
14 1.0 Mild 1/1 0 2/2 0 2/2 2/1 0 1/1 Insignificant
15 1.0 Mild 1/0 1/1 2/2 0 0 0 0 0 Insignificant
16 1.5 Mild 0 0 1/0 0 0 0 0 0 Insignificant
Note. DDAVP = 1-desamino-8-D-arginine-vasopressin. Separate components of speech: IS = independent speech, Rep = repetition, N =
naming, Com = comprehension, W = writing, PA = phonetic analysis, Read = reading, Para = paraphasias. The numbers in the cells
represent the results of investigation prior to treatment course / after 1 course of treatment with DDAVP (in points).
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More often, they were able to read silently correctly and to
match picture to text. In some patients, there was improvement
of comprehension of situational language, simple instructions
and complex logical grammatical constructions. In 50% of the
patients, there was less difficulty in the phonetic analysis of
words. With treatment with vasopressin, this group of patients
showed a regression of secondary defects of expressive speech.
There was significant improvement of independent speech (p
< .05). Spontaneous speech and dialogue in patients with
acoustico-agnostic aphasia became more detailed, with varied
vocabulary, in combination with a decrease of vocal
disinhibition. On the whole, within the group, there was a
decrease in the frequency of literal paraphasias and sensory
agrammatism. In a majority of cases, there was recovery of
automatic speech, including listing of months of the year (p <
.05). In this group, there was improvement of repetition (p <
.05). In the repetition of complex and foreign words, sound
and speech series, and simple sentences, paraphasia occurred
less frequently. The positive changes in independent speech in
this group correlated with the improvement in object and action
naming (p < .05). In cases of acoustico-agnostic aphasia, the
leading factor of impairment was the sensory component of
speech or audio-verbal gnosis (recognition) (Luria, 1970; Luria
& Hutton, 1977). In this group of subjects, vasopressin led to
significant recovery of the sensory component of speech (p <
.01) (see Figure 1). In 17% of the cases with acoustico-agnostic
aphasia, there was a placebo-effect; however, comparison of
speech after administration of vasopressin showed significant
improvement as compared to the placebo. 
The following is case 2, illustrating the effect of the
neuropeptide vasopressin of the state of speech in acoustico-
agnostic aphasia. Patient no. 8 (see Table 4), 36 years old, had
higher education (by profession, an engineer), and was right-
handed. The patient was admitted for treatment by the
Neurological Rehabilitation Department of the V.M. Bekhterev
Saint Petersburg Psychoneurological Research Institute.
Diagnosis on admittance: sequela of stroke in the watershed
area of the left median cerebral artery, mild acoustico-agnostic
aphasia, mild right-sided hemiparesis, mild right-sided hemi-
anesthesia. On admission, the patient complained of difficulty
speaking and clumsiness in the right extremities.
Neuropsychological testing revealed that the patient’s speech
consisted of phrases, without noticeable agrammatism, but
predicative: In the production of speech there was a
predominance of verbs (see Table 4). There was a tendency
towards vocal disinhibition.  In more complex forms of oral
speech (e.g., story-telling), there were agrammatic turns of
speech. Paraphasias occurred in the repetition of complex,
foreign, and pseudo words, and complex sound and speech
series. In the repetition of sentences, there were incorrect
grammatical agreements of the separate parts of speech. There
was no impairment of pronunciation. Naming was
insignificantly impaired. In object naming, difficulty occurred
only in complicated conditions: during spontaneous speech and
simultaneous naming of several objects. Directed speech was
well understood, although difficulties occurred when there was
an unexpected address in conversation with several persons in
the ward; there was poor apprehension of television and radio
programs. The patient’s speech worsened in the presence of
sound interference. Impairment of comprehension of complex
grammatical constructions typical of the Russian language was
revealed. Retention of speech series was limited to 3-4 words.
There was slight impairment in writing. Infrequently
paragraphias occurred in the writing of syllables, words, dictated
sentences, and independent writing. Phonetic analysis and
reading showed mild impairment. Reading out loud and silently
and text comprehension were intact.  There was slight dyslexia
noted only when reading complex words and pseudo words.
After the administration of arginine-vasopressin in the
above-described standard regimen, expressive speech was
recovered (see Table 4). Spontaneous speech became detailed
without vocal disinhibition. After the course of treatment with
the neuropeptide, sound interference did not affect the
perception of directed speech. In dialogue, there were no longer
agrammatic turns of speech. There was improvement of
complex forms of oral language. In the compilation of
Table 4
The Effect of DDAVP on Speech in patients with Acoustico-Agnostic Aphasia (M ± m, rate)
N Indices of speech activities                             Prior to treatment Following treatment
1.0 Independent speech 1.5 ± 0.1 0.9 ± 0.1*
1.1 Automatic (listing of months) 1.6 ± 0.5 0.5 ± 0.5*
2.0 Repetition 1.8 ± 0.1 1.4 ± 0.1*
3.0 Naming 1.9 ± 0.3 1.2 ± 0.3*
4.0 Writing 2 ± 0.1 1.4 ± 0.1*
4.1 Written naming of items 2.5 ± 0.4 1.6 ± 0.4*
5.0 Reading 1.4 ± 0.2 0.9 ± 0.2*
Note. DDAVP = 1-desamino-8-D-arginine-vasopressin.
N = 1.0, 2.0, 3.0, 4.0, 5.0 =– several parts of speech function, 
1.1, 4.1 = sample components of relative speech function. 
* = significant changes in indices after treatment course with DDAVP (p < .05 in all variances)
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sentences and narratives to illustrations, there were less frequent
verbal substitutions. There was a regression of impairment of
repetition. There was recovery of the repetition of complex,
foreign and pseudo words, and sentences. In object naming,
no paraphasia was noted. There was improvement in the
comprehension of directed speech. Paragraphias occurred less
frequently than previously during dictated and independent
writing. The patient carried out phonetic analysis with ease.
On the whole, there was a decrease in paraphasia. Thus, with
treatment with arginine-vasopressin in a patient with mild
acoustico-agnostic aphasia, there was marked improvement
in speech. There was no placebo-effect.
Twelve patients with acoustico-amnestic and acoustico-
agnostic aphasia received a second course of treatment with
the neuropeptide (see Table 5). Improvement in speech was
noted in 65% of the patients. On the whole, there was further
improvement in independent speech (p < .01), repetition
speech (p < .01), object naming ( p < .01), reading (p <
.01), phonetic analysis (p < .01) and speech comprehension
(p < .01). There was further optimization of expressive and
impressive speech. The effect of the first treatment course
persisted and the second course of treatment with the
neuropeptide induced further improvement in speech. 
Discussion
Under the condition of double blind control, it was
observed that 1-desamino-8-D-arginine-vasopressin, a selective
vasopressin V2-type receptor agonist, induces the recovery
of speech with sensory aphasic disturbances by positively
influencing the expressive and impressive components of
speech. The therapeutic effect of arginine-vasopressin is
typified by regression of primary speech impairment:
optimization of the afferent component of speech in acoustico-
agnostic and of the integrative component or audio-verbal
memory in acoustico-amnestic aphasias, and it was comparable
in efficacy relative to the integrative and sensory components
of speech. The observed effect was persistent and did not
regress after cessation of treatment during the entire follow-
up period. Repetitive courses of treatment induced further
improvement in the speech of these patients. 
The positive effect of the neuropeptide arginine-
vasopressin on speech in acoustico-amnestic aphasia is most
probably due to its mnemotropic properties, as the specificity
of this form of aphasia lies in the selective central impairment
of audio-verbal memory (Luria 1970; Luria & Hutton, 1977),
and vasopressin possesses anti-amnestic properties (Wied et
al., 1993; Vawter et al., 1997). It is considered that
optimization of memory by arginine-vasopressin occurs by
means of its modulation of catecholaminergic, serotoninergic,
and other neurotransmitter systems (Kovacs, Bohus, &
Versteed, 1980; Lanca, Liu, Man, & Kalant, 1995; Winnicka
& Wisniewski, 1998). Probably, this process comprises one
of the components of the compensation of speech impairment.
The current study has shown that after administration
of arginine-vasopressin to patients with acoustico-amnestic
aphasia, during independent speech, there is faster
reproduction of simple words. The speech of such patients
shows less verbal and literal paraphasias, and improvement
in naming objects with simple nouns. Phonetic analysis of
recalled simple words (by illustrations) recovered. It is
known that stimuli expressed with high-frequency, single-
syllable, words are more quickly and more correctly
perceived by the right hemisphere (Goodal, 1984;
Nikolaenko & Egorov, 1998), and phonetic analysis is
specific for the left hemisphere (in right-handed subjects)
(Sperry et al., 1969; Zaidel, 1978). The results obtained and
literature review allow one to conclude that the recovery of
expressive and impressive speech with the administration
Table 5
The Effect of DDAVP on Speech in Patients with Acoustico-Agnostic Aphasia 
Subject Time following Severity of speech Separate components of speech Treatment
no. stroke (years) impairment   IS Rep. N Com W PA Read Para results
1 1.1 Severe 3/2 3/3 3/2 3/2 3/2 3/3 3/2 2/1 Good
2 2 Severe 3/3 2/2 3/3 3/3 3/3 3/3 3/3 3/3 Absent
3 1.2 Moderate 2/1 2/2 3/2 2/2 3/2 3/2 2/1 2/1 Good
4 1.5 Moderate 2/1 2/1 3/2 2/2 3/2 3/2 2/1 2/1 Good
5 1.3 Moderate 2/1 2/2 2/2 1/1 2/1 1/0 1/0 2/1 Good
6 1.5 Mild 1/0 2/1 1/1 1/1 1/1 1/1 1/1 0 Insignificant
7 1.2 Mild 1/0 1/0 1/0 1/0 1/0 1/0 0 1/0 Good
8 1.1 Mild 1/0 1/0 1/1 1/1 1/1 1/1 0 0 Insignificant
9 1.5 Mild 1/0 2/2 1/1 1/1 2/2 1/1 1/1 0 Insignificant
10 1.0 Mild 1/0 1/0 1/0 1/0 1/0 1/0 0 1/0 Good
Note. DDAVP = 1-desamino-8-D-arginine-vasopressin. Separate components of speech: IS = independent speech, Rep = repetition, N =
naming, Com = comprehension, W = writing, PA = phonetic analysis, Read = reading, Para = paraphasias. The numbers in the cells
represent the results of investigation prior to treatment course / after 1 course of treatment with DDAVP (in points).
of vasopressin in patients with acoustico-amnestic aphasia
is likely to be due to the organization of audio-verbal
memory. Furthermore, there was primary activation of
neuronal connection of the intact right hemisphere and
secondary activation within the damaged left hemisphere.
In patients with acoustico-agnostic aphasia, treatment with
vasopressin led to regression in impairment of language gnosis
(recognition), the principal factor leading to speech impairment
in this form of aphasia (Luria, 1970; Luria & Hutton, 1977).
There was a decrease in the severity of primary impairment
of impressive speech and in secondary impairment of
expressive speech. In this group of patients, there was
improvement in writing, including the writing of object names,
silent reading and matching of text to picture. According to
the review of the literature, normally inherent speech, and
silent reading in particular, is accompanied by bilateral neuronal
activation within the sensorimotor cortex, thalami, cerebellum,
and supplementary motor regions (Murphy et al., 1997). This
suggests that the recovery of impressive speech in patients
with acoustico-agnostic aphasia results from the activation of
intact structures of the right hemisphere and secondary
activation of surviving target-neurons in the left hemisphere
by vasopressin. In patients with acoustico-agnostic aphasia in
expressive speech (independent, automatic and repetition
speech, object and action naming), there was a decrease in
vocal disinhibition. With treatment, patients showed a decrease
in amount of paraphasias in tests of repetition of complex and
foreign words, and in the reproduction of series of sounds and
words, and simple sentences. The administration of vasopressin
in this group of patients led to regression of impairment of
the sensory component of speech. The optimization of the
afferent component of speech by the neuropeptide in acoustico-
agnostic aphasia was most likely due to its participation in the
process of regulation of the sensory component of speech both
in impairment and in intact speech. Such an assumption may
be justified, as it is considered that vasotocin in birds—an
analogue of mammal vasopressin—participates in the regulation
of the acoustic component of vocalization (Voorhuis et al.,
1988), and the cerebral control of vocalization in animals and
humans is supposed to share similarities (Bieser & Muller-
Preuss, 1996; Gemba, Miki, & Sasaki, 1997).
To account for the data obtained, it is necessary to bear in
mind that in experiments on damaged central motor systems
in the left hemisphere, vasopressin in a similar dose range
induces the reorganization of intra-central connections leading
to the involvement of the neurons of the intact right hemisphere
in the compensation process (Vartanian, Klementiev Neuimina,
& Novikova, 1994). As the dominant hemisphere in relation
to speech and motor activity coincides in most cases, it is
possible that recovery of speech in cases of central motor speech
impairment was also due to primary activation by vasopressin
of the reserve connection of the intact right hemisphere and
secondary activation of the surviving cells of the left hemisphere.
According to the data of functional magnetic resonance
tomography, during the recovery period after stroke, there
is primary activation of right-sided speech (language)
homotopic regions, whereas the area of the brain tissue
surrounding the infarct is activated much later (Cappa, et
al., 1997; Fernandez et al., 2004; Heiss, Thiel, Kessler, &
Herholz, 2003; Xu et al., 2004). Thus, there is spatial-
temporal reorganization of the brain following focal brain
injury, typified by involvement of both hemispheres in the
compensation-recovery process, with primary activation of
the right hemisphere in left-sided damage.
The present study has demonstrated that vasopressin is
equally effective in the correction of speech impairment in
acoustico-amnestic and acoustico-agnostic aphasias.
Considering literature reviews and the results of the present
study, speech recovery in these cases is due to several factors.
Firstly, there is functional compensation and reorganization
of speech, manifesting in the increased activation of normally
deactivated homologous regions of the right hemisphere.
Secondly, recovery is associated with a simultaneous with
treatment increase of the neuronal activity of the partial
deafferentation of the nerve cells of language zones of the
left hemisphere within the ischemic penumbra. Thirdly,
recovery is associated with the involvement of alternative
pathways of the ipsilateral (left) hemisphere as a result of the
direct action of the neuropeptide. Thus, the therapeutic effect
of vasopressin is a result of the optimization of structural and
functional systems in the formation of speech. During the
study, it was observed that repeated treatment courses with
the neuropeptide induce further improvement in speech,
reflecting the presence of supplementary reserve ability.
According to literature reviews, arginine-vasopressin
possesses neurotrophic properties. In hippocampus cell
cultures, infiltration of the neuropeptide results in an increase
in the amount of dendrites and the length of nerve fibers
(Chen et al., 2000; Wu, Lanca, Liu, Man, & Kalant, 1995).
This suggests that the persistence of the effects of
vasopressin in the correction of speech impairment in aphasia
may be due to similar cytoarchitechtural reorganization.
It is known that in early ontogenesis, even with
widespread brain injury, it is possible to achieve practically
complete compensation of speech (Bryden, 1982). In turn,
vasopressin optimizes the maturation of nerve cells during
this period (Brinton & Gruener, 1987), and possesses
neurotrophic properties (Chen et al., 2000; Wu et al., 1995).
In this consideration, it is probable that speech recovery in
aphasia of varying severity is due to activation by
vasopressin of reparative processes, similar to those
mechanisms that occur in the developing nervous system. 
Thus, it has been shown that arginine-vasopressin improves
speech in acoustico-amnestic and acoustic-agnostic aphasia
by means of activation of the V2-receptors of the central
nervous system and the consecutive reformation of intra-central
connections. The results obtained provide the basis of the
suggestion that the endogenous neuropeptide arginine-
vasopressin participates in the regulation of several components
of speech, both in pathology and, most likely, normally. 
TSIKUNOV AND BELOKOSKOVA186
References
Abo, M., Senoo, A., Watanabe, S., Miyano, S., Doseki, K., Sasaki,
N., Kobayashi, K., Kikuchi, Y., & Yonemoto, K. (2004).
Language-related brain function during word repetition in post-
stroke aphasics. Neuroreport, 15, 1891-1894.
Balonov, L.I., & Deglin, V.L. (1976). Sluch i rech dominantnogo
i subdominantnogo polushari [Hearing and speech of dominant
and nondominant hemispheres]. Leningrad, Nauka.
Beeson, P.M., Bayles, K.A., Rubens, A.B., & Kaszniak, A.W.
(1993). Memory impairment and executive control in
individuals with stroke-induced aphasia. Brain and Language,
45, 253-275.  
Bieser, A., & Muller-Preuss, P. (1996). Auditory responsive cortex
in the squirrel monkey: Neural responses to amplitude-modulated
sounds. Experimental Brain Research, 108, 273-284.
Boyd, S.K. (1997). Brain vasotocin pathways and the control of
sexual behaviors in the bullfrog. Brain Research Bulletin, 44,
345-350.
Brinton, R.E., & Gruener, R. (1987). Vasopressin promotes neurite
growth in cultures in embryonic neurons. Synapse, 1, 329–334.
Brudzynski, S.M., Eckersdorf, B., & Golebiewski H. (1995).
Regional specificity of the emotional-aversive response induced
by carbachol in the cat brain: A quantitative mapping study.
Journal of Psychiatry and Neuroscience, 20, 119-132.
Bryden, M. (1982). Laterality (functional asymmetry in the infant
brain). NY, London
Buckner, R.L., Corbetta, M., Schatz, J., Raichle, M.E., & Petersen,
S.E. (1996). Preserved speech abilities and compensation following
prefrontal damage. Proceedings of the National Academy of
Sciences of the United States of America, 93, 1249-1253.
Cappa, S.F., Perani, D., Grassi, F., Bressi, S., Alberoni, M.,
Franceschi, M., Bettinardi, V., Todde, S., & Fazio, F. (1997).
A PET follow-up study of recovery after stroke in acute
aphasics. Brain and Language, 56, 55-67.
Chen, Q., Patel, R., Sales, A., Oji, G., Kim, J., Monreal, A.W., &
Brinton, R.D. (2000). Vasopressin-induced neurotrophism in
cultured neurons of the cerebral cortex: Dependency on
calcium signaling and protein kinase C activity. Neuroscience,
101, 19-26.
Chertkow, H., Bub, O., Deaudon, C., & Whitehead, V. (1997). On
the status of object concepts in aphasia. Brain and Language,
58, 203-232.
Clark, M. (1994). Communication disorders: What to look for and
when to refer. Geriatrics, 49, 51-55.
Dronkers, N.F., Wilkins, D.P., van Valin, R.D., Jr., Redfern, B.B.,
& Jaeger, J.J. (2004). Lesion analysis of the brain areas involved
in language comprehension. Cognition, 92, 145-177.
Druks, J., & Marshall, J.C. (1995). When passives are easier then
actives: Two case studies of aphasic comprehension. Cognition,
55, 311-331.
Efron, R. (1990). The decline and fall of hemispheric specialization.
Hillsdale, NJ: Erlbaum. 
Eviatar, Z., Zaidel, E., & Menn, L. (1990). Concreteness: Nouns,
verbs and hemispheres. Cortex , 23, 611.
Fernandez, B., Cardebat, D., Demonet, J.F., Joseph, P.A., Mazaux,
J.M., Barat, M., & Allard, M. (2004). Functional MRI follow-
up study of language processes in healthy subjects and during
recovery in a case of aphasia. Stroke, 35, 2171-2176.
Gazzaniga, M.S. (1995). Consciousness and cerebral hemispheres.
The cognitive neurosciences. Cambridge, MA: MIT Press. 
Gemba, H., Miki, N., & Sasaki, K. (1997). Cortical field potentials
preceding vocalization in monkeys. Acta Oto-Laryngologica,
532(Suppl.), 96-98. 
Ghacibeh, G.A., & Heilman, K.M. (2003). Progressive affective
aprosodia and prosoplegia. Neurology, 60, 1192-1194.
Goodal, G. (1984). Morphological complexity and cerebral
lateralization. Neuropsychologia, 3, 375-380. 
Graham, K.S., Hodges, J.R., & Patterson, K. (1994). The
relationship between comprehension and oral reading in
progressive fluent aphasia. Neuropsychologia, 32, 299-316.
Hagoort, P. (1993). Impairment of lexical-semantic processing in
aphasia: Evidence from the processing of lexical ambiguities.
Brain and Language, 45, 189-232.
Heilman, K.M., Leon, S.A., & Rosenbek, J.C. (2004). Affective
aprosodia from a medial frontal stroke. Brain and Language,
89, 411-416.
Heiss W.D., Thiel A., Kessler J., Herholz K. (2003). Disturbance
and recovery of language function: Correlates in PET activation
studies. Neuroimage, 20, 42-49.
Josse, G., & Tzourio-Mazoyer, N. (2004). Hemispheric
specialization for language. Brain Research Brain Research
Review, 44, 1-12.
Karbe, H., Kessler, J., Herhols, K., Fink, G.R., & Heiss, W.D.
(1995). Long-term prognosis of poststroke aphasia studied with
positron emission tomography. Archives of Neurology, 52, 186-
190.
Kassel, N., & Torner, J. (1984). The International Cooperative
Study on timing of aneurism surgery—an update. Stroke, 15,
566-670.
Kerr, J.F.R., Wyllie, A.H., & Currie, A.R. (1972). Apoptosis: A
basic biological phenomenon with wide-ranging implication
in tissue kinetics. British Journal of Cancer, 26, 239-257.
Kovacs, G.L., Bohus, B., & Versteed, D.H. (1980). The interaction
of posterior pituitary neuropeptides with monoaminergic
neurotransmission: Significance in learning and memory
processes. Progress of Brain Research, 53, 123-140.
Lanca, A., Liu, J., Man, H., & Kalant, H. (1995). Peripheral
injection of arginine 8-vasopressin increases Fos in specific
brain areas. European Journal of Pharmacology, 281, 263-269.
Larsen, B., Skinhoj, E., & Lassen, N.A. (1979). Cortical activity
of left and right hemisphere provoked by reading and visual
naming. A rCBF study. Acta Neurologica Scandinavica, 72
(Suppl.), 6.
Loddenkemper, T., Dinner, D.S., Kubu, C., Prayson, R., Bingaman,
W., Dagirmanjian, A., & Wyllie, E. (2004). Aphasia after
hemispherectomy in an adult with early onset epilepsy and
hemiplegia. Journal of Neurology, Neurosurgery and Psychiatry,
75, 149-151.
Luria, A.R. (1970). Traumatic Aphasia. The Hague, Mouton. 
INFLUENCE OF VASOPRESSIN ON SPEECH     187
Luria, A.R., & Hutton G.T. (1977). Modem assessment of the basic
forms of aphasia. Brain and Language, 4.
Martin, R.C., & He, T. (2004). Semantic short-term memory and
its role in sentence processing: A replication. Brain and
Language, 89, 76-82. 
Murphy, K., Corfield, D.R., Guz, A., Fink, G.R., Wise, R.J.S.,
Harrison, J., & Adams, L. (1997). Cerebral areas associated
with motor control of speech in humans. Journal of Applied
Physiology, 83, 1438-1447.
Nikiforov, A.S. (1997). Afasia [Aphasia]. Zhurnal Neuropatologii
i Psikhiatrii imeni S.S. Korsakova, 9, 50-52.
Nikolaenko, N.N., & Egorov, A.Y. (1998). Types of interhemispheric
relations in man. Brain and Cognition, 37, 116-119.
Nitatori, T. (1995). Delayed neuronal death in the CA1 pyramidal
cell layer of the gerbil hippocampus following transient
ischemia is apoptosis. Journal of Neuroscience, 15, 1001-1011.
Njiokikjien, C., de Sonneville, L., & Vaal, L. (1994). Callosal size
in children with learning disabilities. Behavioural Brain
Research, 64, 213-218.
Pedersen, P.M., Jorgensen, H.S., Nakayama, H., Raaschou, H.O.,
& Olsen, T.S. (1995). Aphasia in acute stroke: Incidence,
determinants, and recovery. Annals of Neurology, 38, 659-666. 
Perani, D., Cappa, S.F., Tettamanti, M., Rosa, M., Scifo, P., Miozzo,
A., Basso, A., & Fazio, F. (2003). A fMRI study of word
retrieval in aphasia. Brain and Language, 85, 357-368. 
Radanovic, M., & Scaff, M. (2003). Speech and language
disturbances due to subcortical lesions. Brain and Language,
84, 337-352.
Ronnberg, J., Larsson, C., Fogelsjoo, A., Nilsson, L.G., Lindberg,
M., & Angquist, K.A. (1996). Memory dysfunction in mild
aphasics. Scandinavian Journal of Psychology, 37, 46-61.
Saygin, A.P., Wilson, S.M., Dronkers, N.F., & Bates, E. (2004).
Action comprehension in aphasia: Linguistic and non-linguistic
deficits and their lesion correlates. Neuropsychologia, 42, 1788-
1804.
Semmens, J. (1968). Hemispheric specialization: A possible clue
to mechanism. Neuropsychologia, 6, 11-26. 
Sharp, D.J., Scott, S.K., & Wise, R.J. (2004). Retrieving meaning
after temporal lobe infarction: The role of the basal language
area. Annals of Neurology, 56, 836-846. 
Sperry, R.H., Gazzaniga, M.S., & Bogen, J.E. (1969).
Interhemispheric relationships. The neocortical commissures:
Syndromes of hemispheric disconnection. In P.J. Vinken &
G.W. Bruyer (Eds.), Handbook of clinical neurology, 4,
Amsterdam. 
Ullman, M.T. (2004). Contributions of memory circuits to language:
The declarative/procedural model. Cognition, 92, 231-270. 
Vartanian, G.A., Klementiev, B.I., Neuimina, M.V., & Novikova,
T.A. (1994). Neirogumoralnaya induktsia strukturnoi i
funktsionalnoi kompensatornoi reorganizatsii povrezshdennogo
mozga [Neurohumoral induction of structural and functional
compensatory reorganization of the damaged brain]. Vestnik
Rossiiyskoy AMN, 1, 25-27.
Vartanian, G.A., & Klementiev, B.I. (1991). Himichescaya
simmetrya i asimetriya mozqa [The chemical symmetry and
asymmetry of the brain]. Leningrad, Nauka, 101-128.
Vasserman, L.E., Dorofeeva, S.A., & Meerson, I.A. (1997). Metody
neiropsihologicheskoi diagnostiki [Methods of
neuropsychological diagnostics]. Saint Petersburg, 15-300.
Vawter, M.P., de Wied D., & van Ree, J.M. (1997). Vasopressin
fragment, AVP-(4-8), improves long-term and short-term
memory in the whole board search task. Neuropeptides, 31,
489-494. 
Vilenski, B.S. (1995). Insult [Stroke]. Saint Petersburg, Medical
Informational Agency, 24-25.
Voorhuis, Th. A.M., de Kloet, E.R., & de Wied D. (1988). The
distribution and plasticity of (3H) vasopressin labeled specific
bindings sites in the canary brain. Brain Research, 457, 148. 
Ween, J.E., Verfaellie, M., & Alexander, M.P. (1996).Verbal memory
function in mild aphasia. Neurology, 47, 795-801. 
Weiller, C., Isensee, C., Rijntjes, M., Huber, W., Muller, S., Bier,
D., Dutschka, K., Woods, R.P., Noth, J., & Diener, H.C. (1995).
Recovery from Wernicke’s aphasia: A positron emission
tomographic study. Annals of Neurology, 37, 723-732.
Wied de, D., Diamant, M., & Fodor, M. (1993). Central nervous
system effects of the neurohypophyseal hormones and related
peptides. Frontiers in Neuroendocrinology, 14, 251-302. 
Winnicka, M.M., & Wisniewski, K. (1998). 6-OHDA bilateral lesions
to the nucleus septi lateralis attenuate vasopressin improvement
of recall in rats. Pharmacological Research, 37, 145-150.
Wise, R.J. (2003). Language systems in normal and aphasic human
subjects: Functional imaging studies and inferences from animal
studies. British Medical Bulletin, 65, 95-119. 
Whisnant, J.P., Basford J. K., & Bernstein E.F. (1990). Classification
of cerebrovascular diseases. Part III. Stroke, 21, 637-676. 
Wu, P.H., Lanca, A.J., Liu, J.F., Man, C., & Kalant, H. (1995).
Peripheral injection of arginin-8-vasopressin increases Fos in
specific brain areas. European Journal of Pharmacology, 281,
263-269.
Xu, X.J., Zhang, M.M., Shang, D.S., Wang, Q.D., Luo, B.Y., &
Weng, X.C. (2004). Cortical language activation in aphasia: A
functional MRI study. Clinical Medical Journal, 117, 1011-
1016.
Zahn, R., Drews, E., Specht, K., Kemeny, S., Reith, W., Willmes,
K., Schwarz, M., & Huber W. (2004). Recovery of semantic
word processing in global aphasia: A functional MRI study.
Brain Research Cognition Brain Research, 18, 322-336.
Zaidel, E. (1978). Lexical organization in right hemisphere. In R.
Buser & P. Rougel (Eds.), Cerebral correlates of conscious
experience. Elsevier. 
Zaidel, E. (1989). Hemispheric independence and interaction in
word recognition. Brain and Reading, 54, 77.
Received September, 22, 2005
Revision received December, 12, 2006
Accepted  February 6, 2007
TSIKUNOV AND BELOKOSKOVA188
